We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Once hailed by President Trump and others as a possible treatment for COVID-19, the antimalarial drug hydroxychloroquine continues to a thumbs down in a number of human studies, most recently for treatment of patients with mild infections and for hospitalized patients. Read More
Johnson & Johnson has announced that it will begin evaluating its experimental COVID-19 vaccine in its first clinical trial next week, beginning in Belgium on July 22 and the U.S. the following week. Read More
As research on COVID-19 vaccines advances at an unprecedented pace, Russian hackers have been attempting to steal research information, the UK’s National Cyber Security Centre (NCSC) reported Thursday. Read More
The FDA said yesterday that it has reviewed more than 230 clinical trials of potential COVID-19 treatments so far through its Coronavirus Treatment Acceleration Program (CTAP). Read More